Hypouricemic Therapy: A Novel Potential Therapeutic Option for Nonalcoholic Fatty Liver Disease

被引：26
作者：
Xu, Cheng-Fu [1 ]
Yu, Chao-Hui [1 ]
Xu, Lei [1 ,2 ]
Sa, Xiao-Ying [3 ]
Li, You-Ming [1 ]
机构：
[1] Zhejiang Univ, Dept Gastroenterol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
[2] Ningbo 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China
[3] Zhejiang Acad Med Sci, Ctr Expt Anim, Hangzhou, Zhejiang, Peoples R China
来源：
HEPATOLOGY | 2010年 / 52卷 / 05期
关键词：
D O I：
10.1002/hep.23798
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1865 / 1866
页数：2
相关论文
共 50 条
  • [21] Valproate therapy and nonalcoholic fatty liver disease
    Luef, GJ
    Waldmann, M
    Sturm, W
    Naser, A
    Trinka, E
    Unterberger, I
    Bauer, G
    Lechleitner, M
    [J]. ANNALS OF NEUROLOGY, 2004, 55 (05) : 729 - 732
  • [22] Nutritional therapy for nonalcoholic fatty liver disease
    Dongiovanni, Paola
    Lanti, Claudia
    Riso, Patrizia
    Valenti, Luca
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2016, 29 : 1 - 11
  • [23] Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
    Durazzo, Marilena
    Belci, Paola
    Collo, Alessandro
    Grisoglio, Enrica
    Bo, Simona
    [J]. INTERNATIONAL JOURNAL OF HEPATOLOGY, 2012, 2012
  • [24] Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis
    Kluwe, J
    Lohse, AW
    [J]. INTERNIST, 2005, 46 (12): : 1324 - +
  • [25] New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans
    Eugenia Inzaugarat, Maria
    De Matteo, Elena
    Baz, Placida
    Lucero, Diego
    Claudia Garcia, Cecilia
    Ballerga, Esteban Gonzalez
    Daruich, Jorge
    Sorda, Juan Antonio
    Wald, Miriam Ruth
    Claudia Chernavsky, Alejandra
    [J]. PLOS ONE, 2017, 12 (03):
  • [26] Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease
    Sui, Yutong
    Geng, Xue
    Wang, Ziwei
    Zhang, Jing
    Yang, Yanqun
    Meng, Ziyu
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 157
  • [27] A Review of the Therapeutic Potential of Ginseng and Its Bioactive Components in Nonalcoholic Fatty Liver Disease
    Hao, Liyuan
    Li, Shenghao
    Li, Caige
    Zhang, Zhiqin
    Hu, Xiaoyu
    Yan, Huimin
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 83 - 96
  • [28] SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
    Colak, Yasar
    Ozturk, Oguzhan
    Senates, Ebubekir
    Tuncer, Ilyas
    Yorulmaz, Elif
    Adali, Gupse
    Doganay, Levent
    Enc, Feruze Yilmaz
    [J]. MEDICAL SCIENCE MONITOR, 2011, 17 (05): : HY5 - HY9
  • [29] Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
    Lin, Chuan-Hao
    Kohli, Rohit
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
  • [30] Therapeutic Potential of Beta Hydroxybutyrate in Nonalcoholic Fatty Liver Disease (NAFLD)-Induced Cardiovascular
    Badmus, Olufunto O.
    Taylor, Lucy C.
    Greer, Jennifer R.
    McGowan, Karis E.
    Hinds, Terry
    Stec, David E.
    [J]. CIRCULATION, 2023, 148
12345